Nuclear imagers adjust to to practice without Mo-99
Nuclear imagers are using alternatives to keep their practices alive until the National Research Universal Reactor at Chalk River, ON, resumes production of Mo-99
Nuclear imagers are using alternatives to keep their practices alive until the National Research Universal Reactor at Chalk River, ON, resumes production of Mo-99. The shutdown has disrupted 60% of radiopharmacies in the U.S., according to an online survey jointly sponsored by the SNM and the National Association of Nuclear Pharmacies.
Only a third of respondents said they have an alternate source of Mo-99/Tc-99m generators, namely manufacturers with access to isotopes produced in reactors outside of North America. About 84% have eluted older generators more often to draw off as much technetium isotope as possible; 82% are using thallium-201 for cardiac imaging; 6% are performing F-18 FDG-PET bone imaging; and about 9% have shifted to F-18 sodium fluoride (NaF). Indium-111 (5%), gallium-67 (2%), and nitrogen-14 ammonia (1%) were also cited as alternatives.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
